Affimed N.V. AFMD

NAS: AFMD | ISIN: NL0010872420 17/07/2025

0,018 USD (-47,83%)

(-47,83%) 17/07/2025

Grafiek Affimed N.V.

Grafiek Affimed N.V.

1 dag1d -47,83%
1 week1w -51,35%
1 maand1m -76,35%
3 maanden3m -97,44%
6 maanden6m -98,42%
1 jaar1j -99,67%
5 jaar5j -99,59%

Affimed N.V. in het nieuws

Toon enkel gratis nieuws

10 maart 2021 · Affimed Announces Presentations at the AACR Annual Meeting 2021 · Persbericht

10 maart 2021 · Affimed Announces Continuation of REDIRECT, a Registration-directed Study of AFM13 in PTCL, after Positive Preplanned Interim Futility Analysis · Persbericht

3 februari 2021 · Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors · Persbericht

15 januari 2021 · Affimed Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares · Persbericht

13 januari 2021 · Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares · Persbericht

12 januari 2021 · Affimed Announces Proposed Public Offering of Common Shares · Persbericht

11 januari 2021 · Affimed to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

11 januari 2021 · Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank · Persbericht

7 januari 2021 · Affimed Announces Pipeline and Business Update · Persbericht

Profiel Affimed N.V.

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 148

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe